225 related articles for article (PubMed ID: 25002500)
1. Detouring of cisplatin to access mitochondrial genome for overcoming resistance.
Marrache S; Pathak RK; Dhar S
Proc Natl Acad Sci U S A; 2014 Jul; 111(29):10444-9. PubMed ID: 25002500
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of nanoparticle delivered cisplatin in beagles.
Feldhaeusser B; Platt SR; Marrache S; Kolishetti N; Pathak RK; Montgomery DJ; Reno LR; Howerth E; Dhar S
Nanoscale; 2015 Sep; 7(33):13822-30. PubMed ID: 26234400
[TBL] [Abstract][Full Text] [Related]
3. A Prodrug of Two Approved Drugs, Cisplatin and Chlorambucil, for Chemo War Against Cancer.
Pathak RK; Wen R; Kolishetti N; Dhar S
Mol Cancer Ther; 2017 Apr; 16(4):625-636. PubMed ID: 28148716
[TBL] [Abstract][Full Text] [Related]
4. Precisely Assembled Nanoparticles against Cisplatin Resistance via Cancer-Specific Targeting of Mitochondria and Imaging-Guided Chemo-Photothermal Therapy.
Yang GG; Pan ZY; Zhang DY; Cao Q; Ji LN; Mao ZW
ACS Appl Mater Interfaces; 2020 Sep; 12(39):43444-43455. PubMed ID: 32883070
[TBL] [Abstract][Full Text] [Related]
5. Platin-
Banik B; Ashokan A; Choi JH; Surnar B; Dhar S
Dalton Trans; 2023 Mar; 52(12):3575-3585. PubMed ID: 36723189
[TBL] [Abstract][Full Text] [Related]
6. Overcoming tumor resistance to cisplatin by cationic lipid-assisted prodrug nanoparticles.
Cao ZT; Chen ZY; Sun CY; Li HJ; Wang HX; Cheng QQ; Zuo ZQ; Wang JL; Liu YZ; Wang YC; Wang J
Biomaterials; 2016 Jul; 94():9-19. PubMed ID: 27088406
[TBL] [Abstract][Full Text] [Related]
7. Biodegradable polymeric system for cisplatin delivery: development, in vitro characterization and investigation of toxicity profile.
Alam N; Khare V; Dubey R; Saneja A; Kushwaha M; Singh G; Sharma N; Chandan B; Gupta PN
Mater Sci Eng C Mater Biol Appl; 2014 May; 38():85-93. PubMed ID: 24656356
[TBL] [Abstract][Full Text] [Related]
8. Targeted delivery of a cisplatin prodrug for safer and more effective prostate cancer therapy in vivo.
Dhar S; Kolishetti N; Lippard SJ; Farokhzad OC
Proc Natl Acad Sci U S A; 2011 Feb; 108(5):1850-5. PubMed ID: 21233423
[TBL] [Abstract][Full Text] [Related]
9. Unique Use of Alkylation for Chemo-Redox Activity by a Pt(IV) Prodrug.
Pathak RK; Dhar S
Chemistry; 2016 Feb; 22(9):3029-36. PubMed ID: 26807548
[TBL] [Abstract][Full Text] [Related]
10. A red-light activatable and mitochondrion-targeting Pt
Li Y; Wang Z; Qi Y; Tang Z; Li X; Huang Y
Chem Commun (Camb); 2022 Jul; 58(60):8404-8407. PubMed ID: 35796077
[TBL] [Abstract][Full Text] [Related]
11. Targeted hepatocellular carcinoma therapy: transferrin modified, self-assembled polymeric nanomedicine for co-delivery of cisplatin and doxorubicin.
Zhang X; Li J; Yan M
Drug Dev Ind Pharm; 2016 Oct; 42(10):1590-9. PubMed ID: 26942448
[TBL] [Abstract][Full Text] [Related]
12. PLGA-encapsulated tea polyphenols enhance the chemotherapeutic efficacy of cisplatin against human cancer cells and mice bearing Ehrlich ascites carcinoma.
Singh M; Bhatnagar P; Mishra S; Kumar P; Shukla Y; Gupta KC
Int J Nanomedicine; 2015; 10():6789-809. PubMed ID: 26586942
[TBL] [Abstract][Full Text] [Related]
13. Targeted delivery of cisplatin to prostate cancer cells by aptamer functionalized Pt(IV) prodrug-PLGA-PEG nanoparticles.
Dhar S; Gu FX; Langer R; Farokhzad OC; Lippard SJ
Proc Natl Acad Sci U S A; 2008 Nov; 105(45):17356-61. PubMed ID: 18978032
[TBL] [Abstract][Full Text] [Related]
14. Self-assembled Lipid Nanoparticles for Ratiometric Codelivery of Cisplatin and siRNA Targeting XPF to Combat Drug Resistance in Lung Cancer.
Li C; Li T; Huang L; Yang M; Zhu G
Chem Asian J; 2019 May; 14(9):1570-1576. PubMed ID: 30843348
[TBL] [Abstract][Full Text] [Related]
15. A Platinum(IV) Anticancer Prodrug Targeting Nucleotide Excision Repair To Overcome Cisplatin Resistance.
Wang Z; Xu Z; Zhu G
Angew Chem Int Ed Engl; 2016 Dec; 55(50):15564-15568. PubMed ID: 27736029
[TBL] [Abstract][Full Text] [Related]
16. A prodrug strategy to deliver cisplatin(IV) and paclitaxel in nanomicelles to improve efficacy and tolerance.
Xiao H; Song H; Yang Q; Cai H; Qi R; Yan L; Liu S; Zheng Y; Huang Y; Liu T; Jing X
Biomaterials; 2012 Sep; 33(27):6507-19. PubMed ID: 22727463
[TBL] [Abstract][Full Text] [Related]
17. PGC1α regulates mitochondrial oxidative phosphorylation involved in cisplatin resistance in ovarian cancer cells via nucleo-mitochondrial transcriptional feedback.
Shen L; Zhou L; Xia M; Lin N; Ma J; Dong D; Sun L
Exp Cell Res; 2021 Jan; 398(1):112369. PubMed ID: 33220258
[TBL] [Abstract][Full Text] [Related]
18. Intersection of Inorganic Chemistry and Nanotechnology for the Creation of New Cancer Therapies.
Shah AS; Surnar B; Kolishetti N; Dhar S
Acc Mater Res; 2022 Mar; 3(3):283-296. PubMed ID: 37091880
[TBL] [Abstract][Full Text] [Related]
19. Multipronged Design of Light-Triggered Nanoparticles To Overcome Cisplatin Resistance for Efficient Ablation of Resistant Tumor.
Li Y; Deng Y; Tian X; Ke H; Guo M; Zhu A; Yang T; Guo Z; Ge Z; Yang X; Chen H
ACS Nano; 2015 Oct; 9(10):9626-37. PubMed ID: 26365698
[TBL] [Abstract][Full Text] [Related]
20. Optical Imaging and Gene Therapy with Neuroblastoma-Targeting Polymeric Nanoparticles for Potential Theranostic Applications.
Lee J; Jeong EJ; Lee YK; Kim K; Kwon IC; Lee KY
Small; 2016 Mar; 12(9):1201-11. PubMed ID: 26573885
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
